Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 290789011000036115 | betamethasone (as valerate) 0.02% ointment | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 290790011000036110 | betamethasone (as valerate) 200 microgram / 1 g ointment (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| betamethasone (as valerate) 0.02% ointment | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| betamethasone (as valerate) 0.02% ointment | Is a | betamethasone valerate | true | Inferred relationship | Some | ||
| betamethasone (as valerate) 0.02% ointment | has intended active ingredient | betamethasone valerate | true | Inferred relationship | Some | 1667935775 | |
| betamethasone (as valerate) 0.02% ointment | has Australian BoSS | betamethasone | true | Inferred relationship | Some | 1667935775 | |
| betamethasone (as valerate) 0.02% ointment | has manufactured dose form | ointment | true | Inferred relationship | Some | ||
| betamethasone (as valerate) 0.02% ointment | has unit of use | continuous | true | Inferred relationship | Some | 1667935776 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Celestone-M (betamethasone (as valerate) 200 microgram / 1 g) ointment (trade product unit of use) | Is a | True | betamethasone (as valerate) 0.02% ointment | Inferred relationship | Some | |
| betamethasone (as valerate) 0.02% ointment, 100 g | has MPUU | True | betamethasone (as valerate) 0.02% ointment | Inferred relationship | Some | 1 |
| Antroquoril 0.02% ointment | Is a | True | betamethasone (as valerate) 0.02% ointment | Inferred relationship | Some |
Reference Sets
Medicinal product unit of use reference set
FHIR